Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study

Published:2003-04 Issue:4 Volume:4 Page:581-586
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Karasek Petr,Skacel Tomas,Kocakova Ilona,Bednarik Otakar,Petruzelka Lubos,Melichar Bohuslav,Bustova Ivana,Spurny Vladimir,Trason Tomas

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.4.4.581

Reference19 articles.

1. Marimastat as First-Line Therapy for Patients With Unresectable Pancreatic Cancer: A Randomized Trial

2. Recent Discoveries in Cancer Genetics of Exocrine Pancreatic Neoplasia

3. Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical challenges associated with utility of neoadjuvant treatment in patients with pancreatic ductal adenocarcinoma;European Journal of Surgical Oncology;2022-06

2. First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy;World Journal of Clinical Cases;2020-09-26

3. Nano-delivery of Gemcitabine Derivative as a Therapeutic Strategy in a Desmoplastic KRAS Mutant Pancreatic Cancer;The AAPS Journal;2020-06-22

4. Maintenance monotherapy with Gemcitabine following cisplatin-based primary combination chemotherapy in surgically treated advanced urothelial carcinoma: A matched-pair single institution analysis;Molecular and Clinical Oncology;2016-01-28

5. Use of Multifunctional Sigma-2 Receptor Ligand Conjugates to Trigger Cancer-Selective Cell Death Signaling;Cancer Research;2011-11-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3